Loading...
Header Logo
Keywords
Last Name
Institution

Matthew Johnson

TitleAssociate Professor
InstitutionUniversity of Houston
DepartmentDean, Architecture and Design
Address4800 Calhoun Rd
Houston TX 77004
Phone720-427-4495
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R03DA026523     (JOHNSON, MATTHEW WAYNE)Apr 1, 2009 - Mar 31, 2010
    NIH/NIDA
    Development of a Novel Trial-by-Trial Consequence Human Delay Discounting Task
    Role: Principal Investigator
    R21DA026967     (JOHNSON, MATTHEW WAYNE)Jun 1, 2009 - May 31, 2012
    NIH/NIDA
    Sexual HIV Risk Behavior and Impulsive Decision Making in Cocaine Dependence
    Role: Principal Investigator
    R21DA029823     (JOHNSON, MATTHEW WAYNE)May 1, 2011 - Apr 30, 2013
    NIH/NIDA
    Pharmacotherapy for Cocaine Dependence: d-cycloserine with Contingency Management
    Role: Principal Investigator
    R21DA032717     (JOHNSON, MATTHEW WAYNE)Apr 1, 2012 - Feb 28, 2014
    NIH/NIDA
    HIV Sexual Risk Behavior: Methamphetamine and Delay Discounting of Sexual Rewards
    Role: Principal Investigator
    R01DA032363     (JOHNSON, MATTHEW WAYNE)Aug 1, 2012 - Jun 30, 2015
    NIH/NIDA
    Role of delay discounting in driving HIV sexual risk behavior in cocaine abuse
    Role: Principal Investigator
    R21DA034942     (JOHNSON, MATTHEW WAYNE)Jun 1, 2013 - May 31, 2015
    NIH/NIDA
    Cognitive Training in Adolescents during Treatment for Substance Use Disorders
    Role: Principal Investigator
    R01DA035277     (JOHNSON, MATTHEW WAYNE)Sep 30, 2013 - Jun 30, 2019
    NIH/NIDA
    Development of a Prospective Memory Intervention to Reduce Drug Use and HIV Risk
    Role: Principal Investigator
    R21DA036675     (JOHNSON, MATTHEW WAYNE)Sep 30, 2015 - Aug 31, 2017
    NIH/NIDA
    Effects of Oxytocin on the Human Abuse Liability of Methamphetamine
    Role: Principal Investigator
    R01DA042527     (JOHNSON, MATTHEW WAYNE)Sep 1, 2016 - Jun 30, 2019
    NIH/NIDA
    Dose effects of nicotine: Behavioral economics of cigarette abuse liability
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rostami K, Marsh MN, Johnson MW, Mohaghegh H, Heal C, Holmes G, Ensari A, Aldulaimi D, Bancel B, Bassotti G, Bateman A, Becheanu G, Bozzola A, Carroccio A, Catassi C, Ciacci C, Ciobanu A, Danciu M, Derakhshan MH, Elli L, Ferrero S, Fiorentino M, Fiorino M, Ganji A, Ghaffarzadehgan K, Going JJ, Ishaq S, Mandolesi A, Mathews S, Maxim R, Mulder CJ, Neefjes-Borst A, Robert M, Russo I, Rostami-Nejad M, Sidoni A, Sotoudeh M, Villanacci V, Volta U, Zali MR, Srivastava A. ROC-king onwards: intraepithelial lymphocyte counts, distribution & role in coeliac disease mucosal interpretation. Gut. 2017 Sep 11. PMID: 28893865.
      View in: PubMed
    2. Berry MS, Johnson MW. Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacol Biochem Behav. 2017 Aug 24. PMID: 28843425.
      View in: PubMed
    3. Rostami K, Bold J, Parr A, Johnson MW. Gluten-Free Diet Indications, Safety, Quality, Labels, and Challenges. Nutrients. 2017 Aug 08; 9(8). PMID: 28786929.
      View in: PubMed
    4. Tompkins DA, Huhn AS, Johnson PS, Smith MT, Strain EC, Edwards RR, Johnson MW. To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients. Addiction. 2017 Jun 23. PMID: 28645137.
      View in: PubMed
    5. Herrmann ES, Johnson PS, Bruner NR, Vandrey R, Johnson MW. Morning administration of oral methamphetamine dose-dependently disrupts nighttime sleep in recreational stimulant users. Drug Alcohol Depend. 2017 Sep 01; 178:291-295. PMID: 28686987.
      View in: PubMed
    6. Johnson MW, Johnson PS, Rass O, Pacek LR. Behavioral economic substitutability of e-cigarettes, tobacco cigarettes, and nicotine gum. J Psychopharmacol. 2017 Jul; 31(7):851-860. PMID: 28612651.
      View in: PubMed
    7. Barrett FS, Johnson MW, Griffiths RR. Neuroticism is associated with challenging experiences with psilocybin mushrooms. Pers Individ Dif. 2017 Oct 15; 117:155-160. PMID: 28781400.
      View in: PubMed
    8. Horan WP, Johnson MW, Green MF. Altered experiential, but not hypothetical, delay discounting in schizophrenia. J Abnorm Psychol. 2017 Apr; 126(3):301-311. PMID: 28165261.
      View in: PubMed
    9. Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. J Psychopharmacol. 2017 Jul; 31(7):841-850. PMID: 28095732.
      View in: PubMed
    10. Johnson MW, Herrmann ES, Sweeney MM, LeComte RS, Johnson PS. Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV. Psychopharmacology (Berl). 2017 Feb; 234(4):599-612. PMID: 27921140.
      View in: PubMed
    11. Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol. 2016 Dec; 30(12):1181-1197. PMID: 27909165.
      View in: PubMed
    12. Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. J Psychopharmacol. 2016 Dec; 30(12):1279-1295. PMID: 27856683.
      View in: PubMed
    13. Pacek LR, Rass O, Johnson MW. Knowledge about nicotine among HIV-positive smokers: Implications for tobacco regulatory science policy. Addict Behav. 2017 Feb; 65:81-86. PMID: 27792909.
      View in: PubMed
    14. Collado A, Johnson PS, Loya JM, Johnson MW, Yi R. Discounting of Condom-Protected Sex as a Measure of High Risk for Sexually Transmitted Infection Among College Students. Arch Sex Behav. 2017 Oct; 46(7):2187-2195. PMID: 27699562.
      View in: PubMed
    15. Sweeney MM, Rass O, Johnson PS, Strain EC, Berry MS, Vo HT, Fishman MJ, Munro CA, Rebok GW, Mintzer MZ, Johnson MW. Initial feasibility and validity of a prospective memory training program in a substance use treatment population. Exp Clin Psychopharmacol. 2016 Oct; 24(5):390-399. PMID: 27690506.
      View in: PubMed
    16. Paul MJ, Chisolm MS, Johnson MW, Vandrey RG, Dredze M. Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug Use. J Addict Med. 2016 Sep-Oct; 10(5):324-30. PMID: 27466069.
      View in: PubMed
    17. Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol. 2016 Dec; 30(12):1268-1278. PMID: 27578767.
      View in: PubMed
    18. Dunn KE, Barrett FS, Herrmann ES, Plebani JG, Sigmon SC, Johnson MW. Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug Alcohol Depend. 2016 Nov 01; 168:69-75. PMID: 27615403.
      View in: PubMed
    19. Tompkins DA, Johnson PS, Smith MT, Strain EC, Edwards RR, Johnson MW. Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes. Pain. 2016 08; 157(8):1724-32. PMID: 27075431; PMCID: PMC4949122 [Available on 08/01/17].
      View in: PubMed, PubMed Central
    20. Koffarnus MN, Johnson MW, Thompson-Lake DG, Wesley MJ, Lohrenz T, Montague PR, Bickel WK. Cocaine-dependent adults and recreational cocaine users are more likely than controls to choose immediate unsafe sex over delayed safer sex. Exp Clin Psychopharmacol. 2016 Aug; 24(4):297-304. PMID: 27454677; PMCID: PMC5017011 [Available on 08/01/17].
      View in: PubMed, PubMed Central
    21. Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse. 2017 Jan; 43(1):55-60. PMID: 27441452.
      View in: PubMed
    22. Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans. Int J Neuropsychopharmacol. 2016 Jul; 19(7). PMID: 26874330; PMCID: PMC4966277.
      View in: PubMed, PubMed Central
    23. Sheffer CE, Mackillop J, Fernandez A, Christensen D, Bickel WK, Johnson MW, Panissidi L, Pittman J, Franck CT, Williams J, Mathew M. Initial examination of priming tasks to decrease delay discounting. Behav Processes. 2016 Jul; 128:144-52. PMID: 27179761; PMCID: PMC4942247 [Available on 07/01/17].
      View in: PubMed, PubMed Central
    24. Johnson PS, Sweeney MM, Herrmann ES, Johnson MW. Alcohol Increases Delay and Probability Discounting of Condom-Protected Sex: A Novel Vector for Alcohol-Related HIV Transmission. Alcohol Clin Exp Res. 2016 Jun; 40(6):1339-50. PMID: 27129419; PMCID: PMC4968206 [Available on 06/01/17].
      View in: PubMed, PubMed Central
    25. Meredith SE, Sweeney MM, Johnson PS, Johnson MW, Griffiths RR. Weekly Energy Drink Use Is Positively Associated with Delay Discounting and Risk Behavior in a Nationwide Sample of Young Adults. J Caffeine Res. 2016 Mar 01; 6(1):10-19. PMID: 26989563.
      View in: PubMed
    26. Johnson MW, MacLean KA, Caspers MJ, Prisinzano TE, Griffiths RR. Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans. J Psychopharmacol. 2016 Apr; 30(4):323-9. PMID: 26880225.
      View in: PubMed
    27. Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J Psychopharmacol. 2015 Nov; 29(11):1182-90. PMID: 26442957.
      View in: PubMed
    28. Rass O, Pacek LR, Johnson PS, Johnson MW. Characterizing use patterns and perceptions of relative harm in dual users of electronic and tobacco cigarettes. Exp Clin Psychopharmacol. 2015 Dec; 23(6):494-503. PMID: 26389638; PMCID: PMC4658305 [Available on 12/01/16].
      View in: PubMed, PubMed Central
    29. Duke AN, Johnson MW, Reissig CJ, Griffiths RR. Nicotine reinforcement in never-smokers. Psychopharmacology (Berl). 2015 Dec; 232(23):4243-52. PMID: 26345343.
      View in: PubMed
    30. Tupper KW, Wood E, Yensen R, Johnson MW. Psychedelic medicine: a re-emerging therapeutic paradigm. CMAJ. 2015 Oct 06; 187(14):1054-9. PMID: 26350908; PMCID: PMC4592297 [Available on 10/06/16].
      View in: PubMed, PubMed Central
    31. Herrmann ES, Johnson PS, Johnson MW. Examining Delay Discounting of Condom-Protected Sex Among Men Who Have Sex with Men Using Crowdsourcing Technology. AIDS Behav. 2015 Sep; 19(9):1655-65. PMID: 26066395; PMCID: PMC4845734.
      View in: PubMed, PubMed Central
    32. Hendricks PS, Johnson MW, Griffiths RR. Psilocybin, psychological distress, and suicidality. J Psychopharmacol. 2015 Sep; 29(9):1041-3. PMID: 26395582; PMCID: PMC4721603.
      View in: PubMed, PubMed Central
    33. Rass O, Schacht RL, Buckheit K, Johnson MW, Strain EC, Mintzer MZ. A randomized controlled trial of the effects of working memory training in methadone maintenance patients. Drug Alcohol Depend. 2015 Nov 01; 156:38-46. PMID: 26404954; PMCID: PMC4633307 [Available on 11/01/16].
      View in: PubMed, PubMed Central
    34. Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Johnson MW, Griffiths RR, Riba J. Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans. Int J Neuropsychopharmacol. 2015 Jun 05; 18(12). PMID: 26047623; PMCID: PMC4675976.
      View in: PubMed, PubMed Central
    35. Johnson MW, Johnson PS, Herrmann ES, Sweeney MM. Delay and probability discounting of sexual and monetary outcomes in individuals with cocaine use disorders and matched controls. PLoS One. 2015; 10(5):e0128641. PMID: 26017273; PMCID: PMC4445907.
      View in: PubMed, PubMed Central
    36. Bogenschutz MP, Johnson MW. Classic hallucinogens in the treatment of addictions. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 04; 64:250-8. PMID: 25784600.
      View in: PubMed
    37. Rostami K, Aldulaimi D, Holmes G, Johnson MW, Robert M, Srivastava A, Fléjou JF, Sanders DS, Volta U, Derakhshan MH, Going JJ, Becheanu G, Catassi C, Danciu M, Materacki L, Ghafarzadegan K, Ishaq S, Rostami-Nejad M, Peña AS, Bassotti G, Marsh MN, Villanacci V. Microscopic enteritis: Bucharest consensus. World J Gastroenterol. 2015 Mar 07; 21(9):2593-604. PMID: 25759526; PMCID: PMC4351208.
      View in: PubMed, PubMed Central
    38. Hendricks PS, Thorne CB, Clark CB, Coombs DW, Johnson MW. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. J Psychopharmacol. 2015 Mar; 29(3):280-8. PMID: 25586402.
      View in: PubMed
    39. Sessa B, Johnson MW. Can psychedelic compounds play a part in drug dependence therapy? Br J Psychiatry. 2015 Jan; 206(1):1-3. PMID: 25561484.
      View in: PubMed
    40. Marsh MN, Johnson MW, Rostami K. Rebutting Oberhuber- Again. Gastroenterol Hepatol Bed Bench. 2015; 8(4):303-5. PMID: 26468353; PMCID: PMC4600523.
      View in: PubMed, PubMed Central
    41. Dariotis JK, Johnson MW. Sexual discounting among high-risk youth ages 18-24: implications for sexual and substance use risk behaviors. Exp Clin Psychopharmacol. 2015 Feb; 23(1):49-58. PMID: 25545764; PMCID: PMC4350924.
      View in: PubMed, PubMed Central
    42. Johnson PS, Herrmann ES, Johnson MW. Opportunity costs of reward delays and the discounting of hypothetical money and cigarettes. J Exp Anal Behav. 2015 Jan; 103(1):87-107. PMID: 25388973; PMCID: PMC4428151.
      View in: PubMed, PubMed Central
    43. Rass O, Umbricht A, Bigelow GE, Strain EC, Johnson MW, Mintzer MZ. Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence. Psychol Addict Behav. 2015 Mar; 29(1):237-46. PMID: 25365653; PMCID: PMC4388752.
      View in: PubMed, PubMed Central
    44. Johnson PS, Johnson MW. Investigation of "bath salts" use patterns within an online sample of users in the United States. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):369-78. PMID: 25364987; PMCID: PMC4266324.
      View in: PubMed, PubMed Central
    45. Ray BR, Johnson MW, Cammarata K, Smee DL. Changes in seagrass species composition in northwestern Gulf of Mexico estuaries: effects on associated seagrass fauna. PLoS One. 2014; 9(9):e107751. PMID: 25229897; PMCID: PMC4168134.
      View in: PubMed, PubMed Central
    46. Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. 2014 Nov; 28(11):983-92. PMID: 25213996; PMCID: PMC4286320.
      View in: PubMed, PubMed Central
    47. Johnson MW, Bruner NR, Johnson PS. Cocaine dependent individuals discount future rewards more than future losses for both cocaine and monetary outcomes. Addict Behav. 2015 Jan; 40:132-6. PMID: 25260200; PMCID: PMC4438558.
      View in: PubMed, PubMed Central
    48. Herrmann ES, Hand DJ, Johnson MW, Badger GJ, Heil SH. Examining delay discounting of condom-protected sex among opioid-dependent women and non-drug-using control women. Drug Alcohol Depend. 2014 Nov 01; 144:53-60. PMID: 25190049; PMCID: PMC4252483.
      View in: PubMed, PubMed Central
    49. Hendricks PS, Clark CB, Johnson MW, Fontaine KR, Cropsey KL. Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. J Psychopharmacol. 2014 Jan; 28(1):62-6. PMID: 24399338.
      View in: PubMed
    50. Bickel WK, Johnson MW, Koffarnus MN, MacKillop J, Murphy JG. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu Rev Clin Psychol. 2014; 10:641-77. PMID: 24679180; PMCID: PMC4501268.
      View in: PubMed, PubMed Central
    51. Garcia-Romeu A, Griffiths RR, Johnson MW. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Curr Drug Abuse Rev. 2014; 7(3):157-64. PMID: 25563443; PMCID: PMC4342293.
      View in: PubMed, PubMed Central
    52. Bruner NR, Johnson MW. Demand curves for hypothetical cocaine in cocaine-dependent individuals. Psychopharmacology (Berl). 2014 Mar; 231(5):889-97. PMID: 24217899; PMCID: PMC3945407.
      View in: PubMed, PubMed Central
    53. Blair MG, Nguyen NN, Albani SH, L'Etoile MM, Andrawis MM, Owen LM, Oliveira RF, Johnson MW, Purvis DL, Sanders EM, Stoneham ET, Xu H, Dumas TC. Developmental changes in structural and functional properties of hippocampal AMPARs parallels the emergence of deliberative spatial navigation in juvenile rats. J Neurosci. 2013 Jul 24; 33(30):12218-28. PMID: 23884930; PMCID: PMC4471169.
      View in: PubMed, PubMed Central
    54. Johnson MW, Bruner NR. Test-retest reliability and gender differences in the sexual discounting task among cocaine-dependent individuals. Exp Clin Psychopharmacol. 2013 Aug; 21(4):277-86. PMID: 23834552; PMCID: PMC3880114.
      View in: PubMed, PubMed Central
    55. Vandrey R, Johnson MW, Johnson PS, Khalil MA. Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace. Adolesc Psychiatry (Hilversum). 2013 Apr; 3(2):123-134. PMID: 24921061.
      View in: PubMed
    56. Johnson MW, Griffiths RR. Comparative abuse liability of GHB and ethanol in humans. Exp Clin Psychopharmacol. 2013 Apr; 21(2):112-123. PMID: 23421353; PMCID: PMC3886725.
      View in: PubMed, PubMed Central
    57. Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR. Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. J Sci Study Relig. 2012 Dec; 51(4):721-737. PMID: 23316089.
      View in: PubMed
    58. MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology (Berl). 2013 Mar; 226(2):381-92. PMID: 23135605; PMCID: PMC3581702.
      View in: PubMed, PubMed Central
    59. Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans. Drug Alcohol Depend. 2013 Mar 01; 128(3):206-13. PMID: 22989498; PMCID: PMC3562553.
      View in: PubMed, PubMed Central
    60. McClure EA, Vandrey RG, Johnson MW, Stitzer ML. Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine Tob Res. 2013 Jan; 15(1):139-48. PMID: 22573730; PMCID: PMC3524062.
      View in: PubMed, PubMed Central
    61. Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology (Berl). 2012 Sep; 223(1):1-15. PMID: 22526529; PMCID: PMC3652430.
      View in: PubMed, PubMed Central
    62. Dewar DH, Donnelly SC, McLaughlin SD, Johnson MW, Ellis HJ, Ciclitira PJ. Celiac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol. 2012 Mar 28; 18(12):1348-56. PMID: 22493548; PMCID: PMC3319961.
      View in: PubMed, PubMed Central
    63. Johnson MW. An efficient operant choice procedure for assessing delay discounting in humans: initial validation in cocaine-dependent and control individuals. Exp Clin Psychopharmacol. 2012 Jun; 20(3):191-204. PMID: 22329554; PMCID: PMC3535463.
      View in: PubMed, PubMed Central
    64. Johnson MW, Sewell RA, Griffiths RR. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug Alcohol Depend. 2012 Jun 01; 123(1-3):132-40. PMID: 22129843; PMCID: PMC3345296.
      View in: PubMed, PubMed Central
    65. Johnson MW, Bruner NR. The Sexual Discounting Task: HIV risk behavior and the discounting of delayed sexual rewards in cocaine dependence. Drug Alcohol Depend. 2012 Jun 01; 123(1-3):15-21. PMID: 22055012; PMCID: PMC3290676.
      View in: PubMed, PubMed Central
    66. MacLean KA, Johnson MW, Griffiths RR. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol. 2011 Nov; 25(11):1453-61. PMID: 21956378; PMCID: PMC3537171.
      View in: PubMed, PubMed Central
    67. Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology (Berl). 2011 Dec; 218(4):649-65. PMID: 21674151; PMCID: PMC3308357.
      View in: PubMed, PubMed Central
    68. Rogers GB, Hoffman LR, Johnson MW, Mayer-Hamblett N, Schwarze J, Carroll MP, Bruce KD. Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset. Expert Rev Mol Diagn. 2011 Mar; 11(2):197-206. PMID: 21405970; PMCID: PMC3148893.
      View in: PubMed, PubMed Central
    69. Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug Alcohol Depend. 2011 May 01; 115(1-2):150-5. PMID: 21131142; PMCID: PMC3089685.
      View in: PubMed, PubMed Central
    70. Johnson MW, Strain EC, Griffiths RR. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine. Exp Clin Psychopharmacol. 2010 Aug; 18(4):305-15. PMID: 20695686; PMCID: PMC3528786.
      View in: PubMed, PubMed Central
    71. McLaughlin SD, Walker AW, Churcher C, Clark SK, Tekkis PP, Johnson MW, Parkhill J, Ciclitira PJ, Dougan G, Nicholls RJ, Petrovska L. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg. 2010 Jul; 252(1):90-8. PMID: 20562611; PMCID: PMC3292798.
      View in: PubMed, PubMed Central
    72. McLaughlin SD, Perry-Woodford ZL, Clark SK, Johnson MW, Tekkis PP, Ciclitira PJ, Nicholls RJ. Osteoporosis in patients over 50 years of age following restorative proctocolectomy for ulcerative colitis: is DXA screening warranted? Inflamm Bowel Dis. 2010 Feb; 16(2):250-5. PMID: 19591132.
      View in: PubMed
    73. Johnson MW, Bickel WK, Baker F, Moore BA, Badger GJ, Budney AJ. Delay discounting in current and former marijuana-dependent individuals. Exp Clin Psychopharmacol. 2010 Feb; 18(1):99-107. PMID: 20158299; PMCID: PMC2874198.
      View in: PubMed, PubMed Central
    74. Kirshenbaum AP, Johnson MW, Schwarz SL, Jackson ER. Response disinhibition evoked by the administration of nicotine and nicotine-associated contextual cues. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):97-108. PMID: 19640659; PMCID: PMC2789553.
      View in: PubMed, PubMed Central
    75. Johnson MW, Rogers GB, Bruce KD, Lilley AK, von Herbay A, Forbes A, Ciclitira PJ, Nicholls RJ. Bacterial community diversity in cultures derived from healthy and inflamed ileal pouches after restorative proctocolectomy. Inflamm Bowel Dis. 2009 Dec; 15(12):1803-11. PMID: 19637361.
      View in: PubMed
    76. Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Ciclitira PJ, Sherwood RA, Nicholls JR. Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammation. Eur J Gastroenterol Hepatol. 2009 May; 21(5):544-50. PMID: 19300275.
      View in: PubMed
    77. Johnson MW, Das P, Dewar DH, Forbes A, Ciclitira PJ, Nicholls RJ. Medical management of patients with ileal pouch anal anastomosis after restorative procto-colectomy. Eur J Gastroenterol Hepatol. 2009 Jan; 21(1):9-17. PMID: 19011577.
      View in: PubMed
    78. Johnson MW, Ellis HJ, Asante MA, Ciclitira PJ. Celiac disease in the elderly. Nat Clin Pract Gastroenterol Hepatol. 2008 Dec; 5(12):697-706. PMID: 18941431.
      View in: PubMed
    79. Johnson MW, Bickel WK. An algorithm for identifying nonsystematic delay-discounting data. Exp Clin Psychopharmacol. 2008 Jun; 16(3):264-74. PMID: 18540786; PMCID: PMC2765051.
      View in: PubMed, PubMed Central
    80. Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Forbes A, Bjarnason I, Sherwood RA, Ciclitira P, Nicholls JR. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol. 2008 Mar; 20(3):174-9. PMID: 18301296.
      View in: PubMed
    81. Yi R, Johnson MW, Giordano LA, Landes RD, Badger GJ, Bickel WK. THE EFFECTS OF REDUCED CIGARETTE SMOKING ON DISCOUNTING FUTURE REWARDS: AN INITIAL EVALUATION. Psychol Rec. 2008; 58(2):163-174. PMID: 23825867.
      View in: PubMed
    82. Johnson MW, Bickel WK, Baker F. Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers. Exp Clin Psychopharmacol. 2007 Apr; 15(2):187-94. PMID: 17469942.
      View in: PubMed
    83. Johnson MW, Suess PE, Griffiths RR. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Arch Gen Psychiatry. 2006 Oct; 63(10):1149-57. PMID: 17015817.
      View in: PubMed
    84. Huddy JE, Patel P, Johnson MW, Hamilton-Farrell MR, Ede RJ, Sanderson JD. Hyperbaric oxygen as a treatment for malabsorption in a radiation-damaged short bowel. Eur J Gastroenterol Hepatol. 2006 Jun; 18(6):685-8. PMID: 16702860.
      View in: PubMed
    85. Johnson MW, Bickel WK. Replacing relative reinforcing efficacy with behavioral economic demand curves. J Exp Anal Behav. 2006 Jan; 85(1):73-93. PMID: 16602377; PMCID: PMC1397796.
      View in: PubMed, PubMed Central
    86. Heil SH, Johnson MW, Higgins ST, Bickel WK. Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls. Addict Behav. 2006 Jul; 31(7):1290-4. PMID: 16236455.
      View in: PubMed
    87. Yi R, Johnson MW, Bickel WK. Relationship between cooperation in an iterated prisoner's dilemma game and the discounting of hypothetical outcomes. Learn Behav. 2005 Aug; 33(3):324-36. PMID: 16396079.
      View in: PubMed
    88. Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry. 2005; 66 Suppl 9:31-41. PMID: 16336040.
      View in: PubMed
    89. Johnson MW, Dewar DH, Ciclitira P, Forbes A, Nicholls RJ, Bjarnason I. Use of fecal lactoferrin to diagnose irritable pouch syndrome: a word of caution. Gastroenterology. 2004 Nov; 127(5):1647-8; author reply 1648. PMID: 15521043.
      View in: PubMed
    90. Johnson MW, Bickel WK, Kirshenbaum AP. Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes. Drug Alcohol Depend. 2004 Jun 11; 74(3):253-64. PMID: 15194203.
      View in: PubMed
    91. Baker F, Johnson MW, Bickel WK. Decision-making in state lotteries: half now or all of it later? Psychon Bull Rev. 2003 Dec; 10(4):965-70. PMID: 15000546.
      View in: PubMed
    92. Baker F, Johnson MW, Bickel WK. Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. J Abnorm Psychol. 2003 Aug; 112(3):382-92. PMID: 12943017.
      View in: PubMed
    93. Johnson MW, Bickel WK. Within-subject comparison of real and hypothetical money rewards in delay discounting. J Exp Anal Behav. 2002 Mar; 77(2):129-46. PMID: 11936247; PMCID: PMC1284852.
      View in: PubMed, PubMed Central
    Johnson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (279) concept(s)
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _